{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T14:00:31Z","timestamp":1780063231243,"version":"3.54.0"},"reference-count":48,"publisher":"Hindawi Limited","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1584,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1111\/j.1529-8019.2011.01420.x","type":"journal-article","created":{"date-parts":[[2011,6,20]],"date-time":"2011-06-20T14:07:50Z","timestamp":1308578870000},"page":"320-325","source":"Crossref","is-referenced-by-count":15,"title":["Systemic treatment for alopecia areata"],"prefix":"10.1155","volume":"24","author":[{"given":"NINA","family":"OTBERG","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2011,6,20]]},"reference":[{"key":"10.1111\/j.1529-8019.2011.01420.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1046\/j.0022-202x.2001.01583.x","article-title":"Melanocyte-associated T cell epitopes can function as autoantigens for transfer of alopecia areata to human scalp explants on Prkdc(scid) mice","volume":"117","author":"Gilhar","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01420.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature09114","article-title":"Genome-wide association study in alopecia areata implicates both innate and adaptive immunity","volume":"466","author":"Petukhova","year":"2010","journal-title":"Nature"},{"key":"10.1111\/j.1529-8019.2011.01420.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jaad.2009.10.032","article-title":"Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesis","volume":"62","author":"Alkhalifah","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01420.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2133.1973.tb06672.x","article-title":"Intralesional treatment of alopecia areata with triamcinolone acetonide by jet injector","volume":"88","author":"Abell","year":"1973","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01420.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1365-2133.1987.tb07505.x","article-title":"Alterations in scalp blood flow after the epicutaneous application of 3% minoxidil and 0.1% hexyl nicotinate in alopecia","volume":"117","author":"Bunker","year":"1987","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01420.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2340\/000155555493496","article-title":"Large doses of glucocorticoid in the treatment of alopecia areata","volume":"55","author":"Burton","year":"1975","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/j.1529-8019.2011.01420.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.annder.2010.06.002","article-title":"Treatment of alopecia areata with prednisone in a once-monthly oral pulse","volume":"137","author":"Ait Ourhroui","year":"2010","journal-title":"Ann Dermatol Venereol"},{"key":"10.1111\/j.1529-8019.2011.01420.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jaad.2004.10.873","article-title":"Placebo-controlled oral pulse prednisolone therapy in alopecia areata","volume":"52","author":"Kar","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01420.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/archderm.112.11.1549","article-title":"Prednisone therapy for alopecia areata. A follow-up report","volume":"112","author":"Winter","year":"1976","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01420.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-4362.1996.tb03281.x","article-title":"Pulsed administration of corticosteroids in the treatment of alopecia areata","volume":"35","author":"Sharma","year":"1996","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01420.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0190-9622(98)70009-X","article-title":"Pulse methylprednisolone therapy for severe alopecia areata: an open prospective study of 45 patients","volume":"39","author":"Friedli","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01420.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1056\/NEJM199909233411307","article-title":"Treatment of hair loss","volume":"341","author":"Price","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1529-8019.2011.01420.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1001\/archderm.128.11.1467","article-title":"Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata","volume":"128","author":"Olsen","year":"1992","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01420.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1001\/archderm.114.10.1486","article-title":"Corticosteroids in the treatment of alopecia totalis. Systemic effects","volume":"114","author":"Unger","year":"1978","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01420.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000092287","article-title":"A comparison of the efficacy, relapse rate and side effects among three modalities of systemic corticosteroid therapy for alopecia areata","volume":"212","author":"Kurosawa","year":"2006","journal-title":"Dermatology"},{"key":"10.1111\/j.1529-8019.2011.01420.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0733-8635(05)70010-3","article-title":"The risks of systemic corticosteroid use","volume":"16","author":"Lester","year":"1998","journal-title":"Dermatol Clin"},{"key":"10.1111\/j.1529-8019.2011.01420.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0190-9622(97)70342-6","article-title":"Systemic cyclosporine and low-dose prednisone in the treatment of chronic severe alopecia areata: a clinical and immunopathologic evaluation","volume":"36","author":"Shapiro","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01420.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1600-0625.2009.00937.x","article-title":"Serum levels of IL-18 and sIL-2R in patients with alopecia areata receiving combined therapy with oral cyclosporine and steroids","volume":"19","author":"Lee","year":"2010","journal-title":"Exp Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01420.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0190-9622(90)70032-D","article-title":"Oral cyclosporine for the treatment of alopecia areata. A clinical and immunohistochemical analysis","volume":"22","author":"Gupta","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01420.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"S252","DOI":"10.1016\/j.jaad.2005.03.005","article-title":"Alopecia areata presenting in 2 kidney-pancreas transplant recipients taking cyclosporine","volume":"53","author":"Phillips","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01420.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1440-0960.1996.tb01066.x","article-title":"Alopecia areata in a renal transplant recipient on cyclosporin","volume":"37","author":"Dyall-Smith","year":"1996","journal-title":"Australas J Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01420.x-BIB22|cit22","first-page":"415","article-title":"Multifocal alopecia areata during systemic cyclosporine A therapy","volume":"198","author":"Cerottini","year":"1999","journal-title":"Dermatology"},{"key":"10.1111\/j.1529-8019.2011.01420.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1365-2133.1995.tb00742.x","article-title":"Alopecia areata arising in patients receiving cyclosporin immunosuppression","volume":"132","author":"Davies","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01420.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1080\/09546630701846095","article-title":"Combination therapy of cyclosporine and methylprednisolone on severe alopecia areata","volume":"19","author":"Kim","year":"2008","journal-title":"J Dermatolog Treat"},{"key":"10.1111\/j.1529-8019.2011.01420.x-BIB25|cit25","first-page":"90","article-title":"The effect of methylprednisolone pulse-therapy plus oral cyclosporine in the treatment of alopecia totalis and universalis","volume":"11","author":"Shaheedi-Dadras","year":"2008","journal-title":"Arch Iran Med"},{"key":"10.1111\/j.1529-8019.2011.01420.x-BIB26|cit26","first-page":"252","article-title":"Topical cyclosporin A in alopecia areata","volume":"69","author":"Gilhar","year":"1989","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/j.1529-8019.2011.01420.x-BIB27|cit27","first-page":"507","article-title":"Treatment of severe alopecia areata with topical applications of cyclosporin A","volume":"114","author":"Mauduit","year":"1987","journal-title":"Ann Dermatol Venereol"},{"key":"10.1111\/j.1529-8019.2011.01420.x-BIB28|cit28","first-page":"112","article-title":"Treatment of severe alopecia areata by topical applications of cyclosporine: comparative trial versus placebo in 43 patients","volume":"20","author":"de Prost","year":"1988","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1529-8019.2011.01420.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1046\/j.1468-3083.2000.00097-14.x","article-title":"Treatment of alopecia areata in the DEBR model using cyclosporin A lipid vesicles","volume":"14","author":"Verma","year":"2004","journal-title":"Eur J Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01420.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.rdc.2006.12.011","article-title":"Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient","volume":"33","author":"Ranganath","year":"2007","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1111\/j.1529-8019.2011.01420.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"611","DOI":"10.4103\/0378-6323.45103","article-title":"An uncontrolled, open label study of sulfasalazine in severe alopecia areata","volume":"74","author":"Aghaei","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1111\/j.1529-8019.2011.01420.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1365-4632.2008.03700.x","article-title":"Treatment of persistent alopecia areata with sulfasalazine","volume":"47","author":"Rashidi","year":"2008","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01420.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.annder.2010.06.031","article-title":"Long-term follow-up of the efficacy of methotrexate alone or in combination with low doses of oral corticosteroids in the treatment of alopecia areata totalis or universalis","volume":"137","author":"Chartaux","year":"2010","journal-title":"Ann Dermatol Venereol"},{"key":"10.1111\/j.1529-8019.2011.01420.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jaad.2005.09.010","article-title":"The use of methotrexate alone or in combination with low doses of oral corticosteroids in the treatment of alopecia totalis or universalis","volume":"55","author":"Joly","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01420.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jaad.2005.07.059","article-title":"Azathioprine in dermatology: the past, the present, and the future","volume":"55","author":"Patel","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01420.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1365-2133.2004.06323.x","article-title":"Guidelines for prescribing azathioprine in dermatology","volume":"151","author":"Anstey","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01420.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1365-4632.2010.04576.x","article-title":"Could azathioprine be considered as a therapeutic alternative in the treatment of alopecia areata? A pilot study","volume":"49","author":"Farshi","year":"2010","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01420.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jaad.2005.03.039","article-title":"Etanercept does not effectively treat moderate to severe alopecia areata: an open-label study","volume":"52","author":"Strober","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01420.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jaad.2007.10.645","article-title":"Subcutaneous efalizumab is not effective in the treatment of alopecia areata","volume":"58","author":"Price","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01420.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1001\/archderm.142.12.1654","article-title":"Development of alopecia areata universalis in a patient receiving adalimumab","volume":"142","author":"Garcia Bartels","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01420.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2310\/7750.2008.07095","article-title":"Alopecia areata following adalimumab","volume":"13","author":"Kirshen","year":"2009","journal-title":"J Cutan Med Surg"},{"key":"10.1111\/j.1529-8019.2011.01420.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1159\/000162180","article-title":"Alopecia areata universalis during treatment of rheumatoid arthritis with anti-TNF-alpha antibody (adalimumab)","volume":"217","author":"Chaves","year":"2008","journal-title":"Dermatology"},{"key":"10.1111\/j.1529-8019.2011.01420.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000113945","article-title":"Alopecia areata universalis elicited during treatment with adalimumab","volume":"216","author":"Pelivani","year":"2008","journal-title":"Dermatology"},{"key":"10.1111\/j.1529-8019.2011.01420.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1001\/archderm.140.8.1012-a","article-title":"Alopecia areata in a patient using infliximab: new insights into the role of tumor necrosis factor on human hair follicles","volume":"140","author":"Ettefagh","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01420.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000111523","article-title":"Worsening alopecia areata and de novo occurrence of multiple halo nevi in a patient receiving infliximab","volume":"216","author":"Fabre","year":"2008","journal-title":"Dermatology"},{"key":"10.1111\/j.1529-8019.2011.01420.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1001\/archderm.141.6.759","article-title":"Recurrence of alopecia areata in a patient receiving etanercept injections","volume":"141","author":"Posten","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01420.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1540-9740.2006.05443.x","article-title":"Failure of two TNF-alpha blockers to influence the course of alopecia areata","volume":"5","author":"Abramovits","year":"2006","journal-title":"Skinmed"},{"key":"10.1111\/j.1529-8019.2011.01420.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/09273940802596559","article-title":"Alopecia areata during etanercept therapy","volume":"17","author":"Pan","year":"2009","journal-title":"Ocul Immunol Inflamm"}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1529-8019.2011.01420.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1529-8019.2011.01420.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,7]],"date-time":"2024-04-07T20:44:40Z","timestamp":1712522680000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1529-8019.2011.01420.x"}},"subtitle":["Systemic treatment for alopecia areata"],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,5]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1529-8019.2011.01420.x","relation":{},"ISSN":["1396-0296"],"issn-type":[{"value":"1396-0296","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}